Efficacy and Safety of Baricitinib in Managing Severe Alopecia Areata: A 6-Month Real-World Experience

June 2023 in “ British Journal of Dermatology ”

Maria-Angeliki Gkini, Panagiota Tagka, Theofanis Rigatos, Markos Papakonstantis

baricitinib alopecia areata Severity of Alopecia Tool SALT score eyebrow regrowth eyelash regrowth nail involvement PHQ-9 GAD-7 DLQI acneiform rash upper respiratory infection vaginal infection creatine kinase dyslipidaemia neutropenia anaemia AA nail improvement depression score anxiety score quality of life score rash respiratory infection cholesterol issues low white blood cells low red blood cells

From the encyclopedia

Baricitinib →

JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

Alopecia Areata →

autoimmune disorder causing patchy hair loss

Studysummary This study observed that baricitinib treatment led to significant improvements in hair regrowth and quality of life scores in adults with severe alopecia areata over 24 weeks, with an acceptable safety profile as most adverse effects were transient.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on academic.oup.com →

Discuss this study in the Community →

Related Research

7 / 7 results

research Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata

2 citations , September 2021 in “JAAD case reports”

This report describes a case of a woman with ophiasis-pattern alopecia areata who experienced significant hair regrowth and maintained it for 6 months after treatment with dupilumab, though she eventually relapsed.

research A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan

6 citations , July 2019 in “Indian Journal of Dermatology”

This study found that tinea capitis was the most common cause of scalp hair loss in children, affecting over half of cases, followed by alopecia areata, seborrheic dermatitis, and other conditions.

research Hair Disorders

August 2018 in “Oxford University Press eBooks”

This chapter reviews inflammatory scalp diseases and hair shedding, focusing on different types of scalp and follicular diseases, and reports no new clinical findings.

research Disorders of Hair

July 2013 in “DeckerMed Family Medicine”

This review discusses various types of alopecia, including androgenetic, diffuse, and cicatricial, along with their diagnosis and treatment, and reports no new experimental findings.

research Topical and Intralesional Therapies for Alopecia Areata

36 citations , May 2011 in “Dermatologic therapy”

This review discusses topical and intralesional treatments for alopecia areata, providing a management strategy based on patient age and disease severity, but reports no new clinical results.

research Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases

109 citations , May 2011 in “Dermatologic Therapy”

This article reviews the characteristics, associations, and diagnostic criteria for alopecia areata and reports no new clinical findings; the authors note the disease's unpredictable course and variable prognosis.

research Diagnosis and Management of the Hair Loss Patient

7 citations , September 1987 in “PubMed”

This paper reviews the main causes of hair loss seen by dermatologists and reports no new clinical findings, emphasizing the need for comprehensive understanding to manage these conditions effectively.